Updated 20:04 GMT, 28 Oct 2026 SPX 7,744.01 +0.28% NDX 29,813.16 +0.55% VIX 16.87 -3.71% GOLD 4,077.30 +0.07% CL 102.52 +2.62% BTC 81,597.92 +0.98%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,077 +0.07% BTC $81,598 +0.98% VIX 16.87 −3.71% latest tape · as of 20:04 UTC
The Screen · Financials

Tradr 2X Short IREN Daily ETF

IREZ · BTS · USD

Under normal market circumstances, the advisor will maintain at least 80% exposure to financial instruments that provide two times inverse leveraged exposure to the daily performance of IREN.

FAIL · Does not pass the screen
22.76 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago

Screened 2026-10-23 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price22.76 USD at the 23 Oct 2026 close
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.00)
  • Last reviewed23 Oct 2026 (5 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y

What this means: price 22.76 against the desk's fair-value range, over the last year.

Current read
Accumulation ?
Screened · screened 2026-10-23
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.00, read 2026-10-23
  • Ethical does not pass the values gate
Price22.76 USD
Ethical score30.0/100
Our investment reviews on this name
2026-10-11Read Accumulation7.47+204.7% to today ✓Markdown gives way to Accumulation
2026-10-02Read Markdown7.47+204.7% to today Accumulation gives way to Markdown after a 34% rise in 4 weeks
2026-09-02Read Accumulation5.57+308.6% to today ✓Markup gives way to Accumulation
2026-08-02Read Markup5.57+308.6% to today ✓Distribution gives way to Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Tradr 2X Short IREN Daily ETF holds its Accumulation at $22.76. The statistical read favours the sellers, held for 50 days.

As held on the ledger · 2026-10-23
PhaseAccumulation
Quantitative stateThe statistical read favours the sellers, held for 50 days
Price at the screen$22.76
ValuationN/A trailing · N/A forward price to earnings
Values screenFAIL · score 30.0
The Workings

Five Screens, Shown in Full

Does not pass. Financial sector: Financial

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Financial sector: Financial Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Tradr 2X Short IREN Daily ETF does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when IREZ's ethical verdict changes

Today IREZ does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

Where & How to Trade

IREZ trades on BTS. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-25 Accumulation $13.09 +0.0% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-10-18 Accumulation $13.09 +75.2% Entry 8

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 75.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-10-11 Accumulation · changed $7.47 +0.0% Entry 7

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-10-02 Markdown · changed $7.47 +34.1% Entry 6

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 34.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-09-02 Accumulation · changed $5.57 +0.0% Entry 5

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-08-02 Markup · changed $5.57 +0.0% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-07-18 Distribution $5.57 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-07-03 Distribution $5.57 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Distribution $5.57 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $8.26 -16.5% · $835 -16.5%
2 months $22.40 -69.2% · $308 -69.2%
3 months $23.22 -70.3% · $297 -70.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever IREZ does next, these words stay.

Tradr 2X Short IREN Daily ETF · IREZ · Accumulation · $22.76
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.